A Phase I Study of TPI 287 - Temozolomide Combination in Melanoma
Clinical trial NCT01067066 · TERMINATED
Trial details
- NCT number
- NCT01067066
- Sponsor
- M.D. Anderson Cancer Center
- Status
- TERMINATED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2010-02-03
- Primary completion
- 2016-07-06
- Enrollment
- 21
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.